Skip to main content
SpringerLink
Log in

Boceprevir/peginterferon-α-2a/ribavirin/telaprevir

Various toxicities: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Curry MP, Bleibel W.Update on the treatment of hepatitis C genotype 1. Journal of Clinical Outcomes Management 19: 422-431, No. 9, Sep 2012. Available from: URL: http://www.turner-white.com/jc/jc01.php - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boceprevir/peginterferon-α-2a/ribavirin/telaprevir. React. Wkly. 1423, 13 (2012). https://doi.org/10.2165/00128415-201214230-00044

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214230-00044

Keywords

Search

Navigation